The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

Sanofi (SNY) and Dren Bio, a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has ...

Eve continues to expand its smart home lineup with the Eve Dimmer Switch, a Matter-over-Thread smart switch that lets you control and dim your lights via Siri or HomeKit. Whether you want bright ...

Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing and delivery of its vaccine portfolio for the 2025-26 ...

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that provide a clearer look at how the Teva-partnered prospect compares to Merck ...

Graphic designer Rob Janoff has debunked the popular 'byte' theory behind Apple's logo. The bite mark in the apple design was intended to ensure the fruit was instantly recognizable ...

Garner deemed John Cassavetes a "pioneer of American independent cinema," while she cited "All About Eve" to be required viewing for all cinephiles. And if those seem like odd pairings ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

Sanofi licensed the antibody from Alopexx Pharmaceuticals, a precursor to the current biotech of the same name, in 2009 but faced challenges such as the slow enrollment (PDF) of a phase 2a trial.

EXCLUSIVE: British TV has featured its fair share of wealth on screen down the years – just think Downton Abbey or Brideshead Revisited – but in Wild Cherry, creator Nicôle Lecky wanted to ...

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp ...